Moderna (NASDAQ:MRNA) Stock Price Down 4.6% After Insider Selling
Moderna, Inc. (NASDAQ:MRNA – Get Free Report) shares fell 4.6% during trading on Tuesday following insider selling activity. The stock traded as low as $109.76 and last traded at $110.15. 2,846,109 shares changed hands during trading, a decline of 64% from the average session volume of 7,846,225 shares. The stock had previously closed at $115.44. […]
More Stories
Ampio Pharmaceuticals (NYSE:AMPE) Earns Sell Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a research report released on Friday. The...
Pool (NASDAQ:POOL) Stock Rating Upgraded by StockNews.com
Pool (NASDAQ:POOL – Get Free Report) was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating...
StockNews.com Downgrades Meritage Homes (NYSE:MTH) to Sell
Meritage Homes (NYSE:MTH – Get Free Report) was downgraded by stock analysts at StockNews.com from a “hold” rating to a...
Aethlon Medical (NASDAQ:AEMD) Coverage Initiated at StockNews.com
Equities research analysts at StockNews.com began coverage on shares of Aethlon Medical (NASDAQ:AEMD – Get Free Report) in a note...
PriceSmart (NASDAQ:PSMT) Cut to Hold at StockNews.com
StockNews.com downgraded shares of PriceSmart (NASDAQ:PSMT – Free Report) from a buy rating to a hold rating in a research...
Clearfield (NASDAQ:CLFD) Rating Lowered to “Sell” at StockNews.com
Clearfield (NASDAQ:CLFD – Get Free Report) was downgraded by stock analysts at StockNews.com from a “hold” rating to a “sell”...